Pharmaceutical firm Smith+Nephew has appointed Dr Deepak Nath as chief executive officer.
Nath is a former president of the diagnostics business at Siemens Healthineers, and previously held a number of senior roles at Abbott Laboratories.
Nath will succeed Roland Diggelmann on 1 April.
Roberto Quarta, chair of Smith+Nephew, said: “I am delighted to welcome Deepak as Smith+Nephew’s incoming CEO. Deepak is a highly experienced leader with a track record of significant improvement in operations and execution at major global healthcare businesses. He is joining us at an inflection point for the business and will bring his drive, experience and expertise to lead the team in delivering our Strategy for Growth at pace.”